Ogle C W, Qiu B S
Department of Pharmacology, Faculty of Medicine, University of Hong Kong.
Experientia. 1993 Apr 15;49(4):304-7. doi: 10.1007/BF01923407.
Treatment 20 min beforehand with an inhibitor of nitric oxide (NO) synthesis NW-nitro-1-arginine methyl ester (L-NAME) (12.5, 25, 50 or 100 mg/kg, s.c.), dose-dependently intensified gastric glandular mucosal ulceration produced by cold-restraint stress. Hexamethonium (20 mg/kg) or atropine (1 mg/kg) pretreatment s.c. 20 min before stress strongly antagonised stress-evoked ulceration, as well as the ulcer-potentiating effects of L-NAME when either cholinoceptor antagonist was given concurrently with the NO inhibitor. Stress-induced mast cell degranulation was not worsened by L-NAME pretreatment. The findings suggest that NO could confer partial protection against stress-induced gastric ulcer formation; its activity is triggered off by the ulcerogenic mechanism of stress.
预先用一氧化氮(NO)合成抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME)(12.5、25、50或100mg/kg,皮下注射)处理20分钟,剂量依赖性地加剧了冷束缚应激所致的胃腺黏膜溃疡。在应激前20分钟皮下注射六甲溴铵(20mg/kg)或阿托品(1mg/kg)预处理,可强烈拮抗应激诱发的溃疡形成,以及当胆碱受体拮抗剂与NO抑制剂同时给予时L-NAME的溃疡增强作用。L-NAME预处理并未使应激诱导的肥大细胞脱颗粒恶化。这些发现提示,NO可能对应激诱导的胃溃疡形成具有部分保护作用;其活性是由应激的致溃疡机制触发的。